Skip to main content
TipRanks
Go Ultimate75% OFF

Immunome (IMNM) Q2 2021 Earnings Report

468 Followers

IMNM Q2 2021 EPS Results

Actual EPS
-$0.46
Consensus EPS
-$0.39
Beat/Miss
Missed by -$0.07
One Year Ago EPS
-$0.81

IMNM Q2 2021 Revenue Results

Actual Revenue
$0
Expected Revenue
$0
Beat/Miss
Met expectations
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2021
Date
08/19/2021
Time
After Close
Conference Call
Thursday, August 19, 2021
IMNM Upcoming Earnings

Immunome's next earnings date is estimated for March 25, 2027, based on past reporting schedules.

Q2 2021 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2021 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2021 Earnings Call Summary

No earnings call summary is available for this earnings event.

IMNM Earnings History

IMNM earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 25, 20272026 (Q4)-0.72--0.76――
Nov 09, 20262026 (Q3)-0.62-0.64-0.651.08% (+0.01)
Aug 11, 20262026 (Q2)-0.51-0.65-0.5-30.00% (-0.15)
May 12, 20262026 (Q1)-0.56-0.48-0.527.69% (+0.04)
Mar 03, 20262025 (Q4)-0.59-0.76-1.1131.53% (+0.35)
Nov 06, 20252025 (Q3)-0.57-0.65-0.7816.67% (+0.13)
Aug 06, 20252025 (Q2)-0.52-0.50-0.616.67% (+0.10)
May 12, 20252025 (Q1)-0.64-0.52-2.5179.28% (+1.99)
Mar 19, 20252024 (Q4)-0.64-1.11-4.2173.63% (+3.10)
Nov 13, 20242024 (Q3)-0.55-0.78-0.36-116.67% (-0.42)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed